Recurrent UTI/VUR Co-Management Note (Pediatric)

Date: [Date] Location: [Clinic/Telehealth site] Encounter Type: [in-person / telehealth] Note Type: Co-Management Note Author(s): [Author name(s) and role(s)]

Care Team and Shared Care Context

Primary Care Clinician: [Name and clinic/practice] (Include if known.)

Consulting/Co-Managing Services: [Pediatric urology / Pediatric nephrology / Both]

Reason for Shared Care: [Brief reason for shared-care arrangement]

Historian: [Parent/guardian/patient/other] (Include interpreter use, language, and any reliability limitations.)

Chief Concern

[Chief concern in patient/family words]

Clinical Summary

[One-sentence anchor: age, sex, key diagnoses (recurrent UTI; VUR grade/laterality if known; BBD/constipation; renal scarring status), current management (prophylaxis vs none; prior surgery), current status (time since last UTI; symptomatic vs well).] (Use "Unknown (records not available)" for safety-critical gaps such as VUR grade or prophylaxis status.)

Interval History

UTI Episode Inventory

(List episodes in chronological order. For each episode, label diagnostic certainty accurately—do not upgrade parent-reported UTIs to culture-confirmed without documentation. If records are missing, note the plan to obtain them.)

• Episode [#]: [Date (mm/yyyy)]; [Age at episode]

  • Fever/systemic symptoms: [Tmax, chills, flank pain, vomiting, toxicity]
  • Urine collection method: [catheter / clean-catch / bag / unknown]
  • Urinalysis: [pyuria, leukocyte esterase, nitrites, other findings]
  • Culture: [Organism and colony count]; [Key susceptibilities/resistance] (If unavailable, state "Unknown (records not available)" and note retrieval plan.)
  • Treatment: [Antibiotic name, route, duration]; [Hospitalization yes/no]
  • Complications: [Sepsis, renal impairment, other, or none]
  • Diagnostic certainty: [Culture-confirmed (records reviewed) / Reported UTI (culture data unavailable) / Possible UTI (treated empirically)]
• (Repeat episode block for each UTI.)

Current Symptoms

[Urinary symptoms: dysuria, urgency, frequency, incontinence; fever; abdominal or flank pain; bowel symptoms including constipation or encopresis] (Include interim ED/urgent care visits or antibiotic exposures since last visit.)

Bladder/Bowel Dysfunction Screening

BBD status: [positive / negative / not assessed today] (Required section per AUA guidelines; avoid vague statements.)

• Voiding symptoms: [urgency, frequency, prolonged intervals, daytime incontinence, nocturnal enuresis, holding maneuvers, weak stream, incomplete emptying]
• Bowel symptoms: [constipation, stool frequency, hard/painful stools, encopresis, withholding behaviors]
• Functional context: [toilet-training status, school bathroom access]
• Tools used: [Validated questionnaire name / voiding diary] with [summary results] (Include only if used.)

Current Prophylaxis and Prevention Measures

• Continuous antibiotic prophylaxis: [agent, dose, schedule, start date, adherence, side effects, breakthrough infections while on prophylaxis] (If none, state none.)
• Non-antibiotic measures: [hydration plan, timed voiding, constipation regimen, perineal hygiene]

Records Reviewed

(List external records reviewed. For key data points, document source as report reviewed, images personally reviewed, or family report only.)

• [PCP notes: date range; key findings]
• [Urine cultures: dates, organisms, resistance patterns; source]
• [Imaging reports: RBUS, VCUG/cystogram, DMSA; source]
• [Hospital/ED summaries: dates; pertinent details]
• [Records pending: what, requested from where, responsible party]

Relevant History

• VUR history: [grade, laterality, duplex system, prior interventions/surgeries] (If not yet evaluated, state "evaluation pending.")
• Prenatal hydronephrosis: [present / absent / unknown]
• Kidney disease/hypertension history: [details or none known]
• Medications: [current medications, including bowel regimen]
• Antibiotic allergies: [agent and reaction type] (If none or unknown, state explicitly.)
• Family history: [VUR or renal disease relevant to management]
• Care barriers: [adherence challenges, access to rapid evaluation, transportation, language]

Objective

Vitals and Growth

BP: [value and percentile] Weight: [value and percentile] Height: [value and percentile] BMI percentile: [value] (Emphasize BP/growth trends if renal scarring or CKD risk present.)

Physical Exam

• General: [well/ill-appearing, hydration status]
• Abdomen: [tenderness, mass, stool burden]
• CVA tenderness: [present / absent]
• External genital/perineal exam: [findings] (Include only when indicated; document consent/chaperone.)

Data Reviewed

Urine Testing: [Most recent UA and culture results; key prior cultures with organisms and resistance patterns]

Imaging Timeline: (Chronological list with date, modality, key findings, and interpretation source. If imaging ordered and pending, note expected date and who will follow results.)

• RBUS: [date] — [kidney size, hydronephrosis, bladder findings]; [source: report reviewed / images personally reviewed / family report]
• VCUG or radionuclide cystogram: [date] — [VUR grade and laterality]; [source]
• DMSA: [date] — [cortical defects/scars]; [source]

Other Labs: [Creatinine/eGFR, urine protein/albumin if monitored; dates]

Assessment

Clinical Synthesis

[Concise synthesis: recurrence pattern (frequency/severity), VUR status (grade/laterality/resolution or unknown), BBD/constipation status, renal scarring status (known/unknown), key risk modifiers (breakthrough febrile UTIs, resistant organisms)] (Distinguish documented facts from clinical impressions.)

Problem List

• [Recurrent UTI: culture-confirmed vs suspected]
• [Vesicoureteral reflux: grade/laterality or evaluation pending]
• [Bladder/bowel dysfunction or constipation]
• [Renal scarring or CKD/hypertension risk]
• [Antibiotic prophylaxis management]
• [Other relevant problems]

Plan

(Organize by problem. For each, document actions today, monitoring plan, contingency, and responsible party.)

Recurrent UTI Prevention and Action Plan

• When symptomatic/febrile: [Where to seek care and how quickly; preferred urine collection method by age; testing to obtain before antibiotics when clinically stable]
• ED criteria: [toxicity, dehydration, age <2 months, inability to tolerate oral intake]
• Responsibility: [PCP vs urology to direct urine collection, order culture, review and communicate results]

VUR Management

[Current VUR status and management strategy: observation vs prophylaxis vs surgical planning] (Include only if VUR diagnosed or strongly suspected; if pending evaluation, state plan.)

• Imaging follow-up: [test, timing/interval, who orders, who follows results]
• Escalation triggers: [breakthrough febrile UTIs, worsening imaging, persistent high-grade reflux]

BBD and Constipation Management

• Interventions: [timed voiding schedule, hydration targets, bowel regimen specifics]
• Referrals: [pelvic floor therapy / GI / continence clinic] (Include if indicated.)
• Monitoring: [voiding/stool diary, school accommodations, follow-up checkpoints]

(If BBD screened negative, document key negatives assessed.)

Antibiotic Prophylaxis Decision

Decision: [start / continue / stop / defer] prophylaxis

Rationale: [Patient-specific risk factors and recurrence history supporting decision]

Regimen: [Agent, dose, schedule, intended duration, stop criteria]

Stewardship considerations: [Prior resistant organisms, recent antibiotic exposures, monitoring for adverse effects]

Renal Scarring Risk Counseling and Monitoring

• Counseling provided: [Plain-language explanation of scarring risk and modifiers discussed with family]
• Monitoring plan: [BP and growth surveillance cadence; urinalysis for proteinuria when indicated]
• Nephrology referral criteria: [bilateral defects, proteinuria, elevated BP, impaired renal function]

Care Coordination and Handoff

• PCP will: [Obtain catheterized urine within specified window of unexplained fever; start empiric antibiotics only after specimen when stable; notify consulting service with results; BP/growth monitoring]
• Urology will: [Interpret imaging; advise on surgical candidacy; manage VUR strategy; communicate results and next steps]
• Nephrology will: [Monitor renal function/BP/proteinuria; manage CKD risk] (Include only if involved.)
• Family will: [Symptom recognition, adherence to prophylaxis/regimen, follow action plan, when to seek urgent care]
• Written care plan provided to: [family / PCP / school; format and date]

Orders

• Medications: [name, dose, route, frequency, duration]
• Labs: [UA, urine culture, creatinine/eGFR, urine protein/albumin]
• Imaging: [RBUS / VCUG or radionuclide cystogram / DMSA; timing]
• Referrals: [urology / nephrology / GI / pelvic floor therapy / continence clinic]

Follow-Up

Next Appointment: [date or interval] with [service] (Specify who schedules.)

Return Precautions: [fever, breakthrough UTI symptoms, medication intolerance, new or worsening incontinence, poor oral intake, other concerning changes]